Jutta Heix: Bridging innovations to improve clinical outcomes for cancer patients
Jutta Heix, Head of International Affairs at Oslo Cancer Cluster, shared on LinkedIn:
“A new year and just two weeks left until the 17th Cancer Crosslinks, Jan 23rd, 2025 in Oslo. We are looking forward to welcoming a distinguished group of leading international experts presenting how they are ‘Bridging innovations to improve clinical outcomes for cancer patients’.
You can look forward to an inspiring program addressing:
Tumor-Agnostic Therapies in Precision Oncology: hear about groundbreaking advancements in tumor-agnostic approaches and how these are transforming cancer therapy and advancing precision medicine beyond traditional histology-based strategies.
The Expanding the Role of Cell Therapies: get an update about the latest developments in cell-based therapies – in particular CAR-T and adoptive T-cell therapies – and their potential to revolutionize treatment for hematological malignancies and solid tumor indications.
Driving Digital Innovation in Clinical Practice: learn about the integration of digital tools and artificial intelligence into clinical workflows in national and international initiatives advancing medical imaging and improving cancer diagnostics.
And of course you have time for informal discussions with your colleagues, researchers, clinicians, regulators, company representatives and our international speakers during the networking parts.
You can still sign-up and join on-site or digitally to create new ‘crosslinks’ inspiring your own work in 2025!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023